Rheumatoid Arthritis

QS scientists have collectively accumulated extensive experience in the areas of rheumatoid arthritis and psoriasis. We have also worked on Crohn’s, systemic sclerosis, and other immunological disorders.

We have developed a RA clinical outcomes database which serves as a great enabling tool in our consulting projects as well as a stand-alone product for interested clients (please see Products section for details on our database offerings). The objective of the database is to include all information on biologic DMARDs as well as synthetic DMARDs currently approved or in development. The indications are rheumatoid arthritis (RA), psoriatic arthritis (PsA), and psoriasis (PSO).

A total of 129 references were selected for inclusion in the database, representing clinical outcomes from 94 unique trials, 301 unique treatment arms and about 38,460 patients. Download a summary description for the RA database.